{"count": 43, "results": [{"_id": "32937023", "pmid": 32937023, "pmcid": "PMC7692919", "title": "Efficacy and safety of co-administered telmisartan/amlodipine and rosuvastatin in subjects with hypertension and dyslipidemia", "journal": "J Clin Hypertens (Greenwich)", "authors": ["Jin X", "Kim MH", "Han KH", "Hong SJ", "Ahn JC", "Sung JH", "Cho JM", "Lee HC", "Choi SY", "Lee K", "Kim WS", "Rhee MY", "Kim JH", "Hong SP", "Yoo BS", "Cho EJ", "Lee JH", "Kim PJ", "Park CG", "Hyon MS", "Shin JH", "Lee SH", "Sung KC", "Hwang J", "Kwon K", "Chae IH", "Seo JS", "Kim H", "Lee H", "Cho Y", "Kim HS"], "date": "2020-10-01T00:00:00Z", "doi": "10.1111/jch.13893", "meta_date_publication": "2020 Oct", "meta_volume": "22", "meta_issue": "10", "meta_pages": "1835-1845", "score": 50273.65, "text_hl": "Efficacy and safety of co-administered @CHEMICAL_Telmisartan @CHEMICAL_MESH:D000077333 @@@telmisartan@@@/@<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@amlodipine@@@ and @CHEMICAL_Rosuvastatin_Calcium @CHEMICAL_MESH:D000068718 @@@rosuvastatin@@@ in subjects with @DISEASE_Hypertension @DISEASE_MESH:D006973 @@@hypertension@@@ and @<m>DISEASE_Dyslipidemias</m> @DISEASE_MESH:D050171 @@@dyslipidemia@@@", "citations": {"NLM": "Jin X, Kim MH, Han KH, Hong SJ, Ahn JC, Sung JH, Cho JM, Lee HC, Choi SY, Lee K, Kim WS, Rhee MY, Kim JH, Hong SP, Yoo BS, Cho EJ, Lee JH, Kim PJ, Park CG, Hyon MS, Shin JH, Lee SH, Sung KC, Hwang J, Kwon K, Chae IH, Seo JS, Kim H, Lee H, Cho Y, Kim HS. Efficacy and safety of co-administered telmisartan/amlodipine and rosuvastatin in subjects with hypertension and dyslipidemia J Clin Hypertens (Greenwich). 2020 Oct;22(10):1835-1845. PMID: 32937023", "BibTeX": "@article{32937023, title={Efficacy and safety of co-administered telmisartan/amlodipine and rosuvastatin in subjects with hypertension and dyslipidemia}, author={Jin X and Kim MH and Han KH and Hong SJ and Ahn JC and Sung JH and Cho JM and Lee HC and Choi SY and Lee K and Kim WS and Rhee MY and Kim JH and Hong SP and Yoo BS and Cho EJ and Lee JH and Kim PJ and Park CG and Hyon MS and Shin JH and Lee SH and Sung KC and Hwang J and Kwon K and Chae IH and Seo JS and Kim H and Lee H and Cho Y and Kim HS}, journal={J Clin Hypertens (Greenwich)}, volume={22}, number={10}, pages={1835-1845}}"}}, {"_id": "32109991", "pmid": 32109991, "pmcid": "PMC7036667", "title": "Comparison of Pharmacokinetics of a Fixed-Dose Combination of Amlodipine/Losartan/Rosuvastatin with Concomitant Administration of Amlodipine/Losartan and Rosuvastatin in Healthy Volunteers", "journal": "Drug Des Devel Ther", "authors": ["Yoon DY", "Park SI", "Jung JA", "Kim YI", "Jang IJ", "Chung JY"], "date": "2020-02-19T00:00:00Z", "doi": "10.2147/DDDT.S233014", "meta_date_publication": "2020", "meta_volume": "14", "meta_issue": "", "meta_pages": "661-668", "score": 50267.32, "text_hl": "A fixed-dose combination (FDC) tablet formulation of @<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@amlodipine@@@/@CHEMICAL_Losartan @CHEMICAL_MESH:D019808 @@@losartan@@@/@CHEMICAL_Rosuvastatin_Calcium @CHEMICAL_MESH:D000068718 @@@rosuvastatin@@@ 5/100/20 mg was developed to improve medication compliance in @SPECIES_9606 @@@patients@@@ with both @DISEASE_Hypertension @DISEASE_MESH:D006973 @@@hypertension@@@ and @<m>DISEASE_Dyslipidemias</m> @DISEASE_MESH:D050171 @@@dyslipidemia@@@. ", "citations": {"NLM": "Yoon DY, Park SI, Jung JA, Kim YI, Jang IJ, Chung JY. Comparison of Pharmacokinetics of a Fixed-Dose Combination of Amlodipine/Losartan/Rosuvastatin with Concomitant Administration of Amlodipine/Losartan and Rosuvastatin in Healthy Volunteers Drug Des Devel Ther. 2020;14():661-668. PMID: 32109991", "BibTeX": "@article{32109991, title={Comparison of Pharmacokinetics of a Fixed-Dose Combination of Amlodipine/Losartan/Rosuvastatin with Concomitant Administration of Amlodipine/Losartan and Rosuvastatin in Healthy Volunteers}, author={Yoon DY and Park SI and Jung JA and Kim YI and Jang IJ and Chung JY}, journal={Drug Des Devel Ther}, volume={14}, pages={661-668}}"}}, {"_id": "36451242", "pmid": 36451242, "pmcid": "PMC9714199", "title": "A randomized, double-blind, multicenter, phase III study on the efficacy and safety of a combination treatment involving fimasartan, amlodipine, rosuvastatin in patients with essential hypertension and dyslipidemia who fail to respond adequately to fimasartan monotherapy", "journal": "Clin Hypertens", "authors": ["Jeon ES", "Lim SW", "Kim SY", "Yang HM", "Kim MH", "Rhee MY", "Han SH", "Shin J", "Kim KI", "Jeong JO", "Sung KC", "Hong GR", "Kim HS", "Kwon K", "Kang TS", "Lee HY", "Han SE"], "date": "2022-12-01T00:00:00Z", "doi": "10.1186/s40885-022-00223-4", "meta_date_publication": "2022 Dec 1", "meta_volume": "28", "meta_issue": "1", "meta_pages": "40", "score": 50267.156, "text_hl": "Based on the facts mentioned above, we intend to develop a combination therapy involving @CHEMICAL_fimasartan @CHEMICAL_MESH:C558933 @@@fimasartan@@@, @<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@amlodipine@@@, and @CHEMICAL_Rosuvastatin_Calcium @CHEMICAL_MESH:D000068718 @@@rosuvastatin@@@, which are already commercially available drugs for @DISEASE_Hypertension @DISEASE_MESH:D006973 @@@hypertension@@@ and @<m>DISEASE_Dyslipidemias</m> @DISEASE_MESH:D050171 @@@dyslipidemia@@@. ", "citations": {"NLM": "Jeon ES, Lim SW, Kim SY, Yang HM, Kim MH, Rhee MY, Han SH, Shin J, Kim KI, Jeong JO, Sung KC, Hong GR, Kim HS, Kwon K, Kang TS, Lee HY, Han SE. A randomized, double-blind, multicenter, phase III study on the efficacy and safety of a combination treatment involving fimasartan, amlodipine, rosuvastatin in patients with essential hypertension and dyslipidemia who fail to respond adequately to fimasartan monotherapy Clin Hypertens. 2022 Dec 1;28(1):40. PMID: 36451242", "BibTeX": "@article{36451242, title={A randomized, double-blind, multicenter, phase III study on the efficacy and safety of a combination treatment involving fimasartan, amlodipine, rosuvastatin in patients with essential hypertension and dyslipidemia who fail to respond adequately to fimasartan monotherapy}, author={Jeon ES and Lim SW and Kim SY and Yang HM and Kim MH and Rhee MY and Han SH and Shin J and Kim KI and Jeong JO and Sung KC and Hong GR and Kim HS and Kwon K and Kang TS and Lee HY and Han SE}, journal={Clin Hypertens}, volume={28}, number={1}, pages={40}}"}}, {"_id": "35054044", "pmid": 35054044, "pmcid": "PMC8779537", "title": "A Prospective Randomized, Double-Blind, Multi-Center, Phase III Clinical Trial Evaluating the Efficacy and Safety of Olmesartan/Amlodipine plus Rosuvastatin Combination Treatment in Patients with Concomitant Hypertension and Dyslipidemia: A LEISURE Study", "journal": "J Clin Med", "authors": ["Jo SH", "Kang SM", "Yoo BS", "Lee YS", "Youn HJ", "Min K", "Yu JM", "Yoon HJ", "Kim WS", "Kim GH", "Park JH", "Kim SY", "Kim CH"], "date": "2022-01-11T00:00:00Z", "doi": "10.3390/jcm11020350", "meta_date_publication": "2022 Jan 11", "meta_volume": "11", "meta_issue": "2", "meta_pages": "", "score": 50266.945, "text_hl": "We tested a well-known drugs combination, @CHEMICAL_olmesartan @CHEMICAL_MESH:C437965 @@@olmesartan@@@ and @<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@amlodipine@@@ as antihypertensive medication, and @CHEMICAL_Rosuvastatin_Calcium @CHEMICAL_MESH:D000068718 @@@rosuvastatin@@@ as an anti-@<m>DISEASE_Dyslipidemias</m> @DISEASE_MESH:D050171 @@@dyslipidemia@@@ drug. ", "citations": {"NLM": "Jo SH, Kang SM, Yoo BS, Lee YS, Youn HJ, Min K, Yu JM, Yoon HJ, Kim WS, Kim GH, Park JH, Kim SY, Kim CH. A Prospective Randomized, Double-Blind, Multi-Center, Phase III Clinical Trial Evaluating the Efficacy and Safety of Olmesartan/Amlodipine plus Rosuvastatin Combination Treatment in Patients with Concomitant Hypertension and Dyslipidemia: A LEISURE Study J Clin Med. 2022 Jan 11;11(2):. PMID: 35054044", "BibTeX": "@article{35054044, title={A Prospective Randomized, Double-Blind, Multi-Center, Phase III Clinical Trial Evaluating the Efficacy and Safety of Olmesartan/Amlodipine plus Rosuvastatin Combination Treatment in Patients with Concomitant Hypertension and Dyslipidemia: A LEISURE Study}, author={Jo SH and Kang SM and Yoo BS and Lee YS and Youn HJ and Min K and Yu JM and Yoon HJ and Kim WS and Kim GH and Park JH and Kim SY and Kim CH}, journal={J Clin Med}, volume={11}, number={2}}"}}, {"_id": "37584254", "pmid": 37584254, "pmcid": "PMC10497028", "title": "Randomized, multicenter, parallel, open, phase 4 study to compare the efficacy and safety of rosuvastatin/amlodipine polypill versus atorvastatin/amlodipine polypill in hypertension patient with dyslipidemia", "journal": "J Clin Hypertens (Greenwich)", "authors": ["Jung HW", "Kim CY", "Hong SP", "Bae HJ", "Choi JY", "Ryu JK", "Lee JB", "Lee KH", "Han KR", "Yang DH", "Park CG", "Yu GW", "Rhee MY", "Park SJ", "Hyon MS", "Shin JH", "Hong BK", "Jin HY", "Lee SY", "Seol SH", "Lee SR", "Kim SY", "Lee KJ", "Cho EJ", "Nam CW", "Park TH", "Kim U", "Kim KS"], "date": "2023-08-16T00:00:00Z", "doi": "10.1111/jch.14715", "meta_date_publication": "2023 Aug 16", "meta_volume": "", "meta_issue": "", "meta_pages": "", "score": 50265.74, "text_hl": "Randomized, multicenter, parallel, open, phase 4 study to compare the efficacy and safety of @CHEMICAL_Rosuvastatin_Calcium @CHEMICAL_MESH:D000068718 @@@rosuvastatin@@@/@<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@amlodipine@@@ polypill versus @CHEMICAL_Atorvastatin @CHEMICAL_MESH:D000069059 @@@atorvastatin@@@/@<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@amlodipine@@@ polypill in @DISEASE_Hypertension @DISEASE_MESH:D006973 @@@hypertension@@@ @SPECIES_9606 @@@patient@@@ with @<m>DISEASE_Dyslipidemias</m> @DISEASE_MESH:D050171 @@@dyslipidemia@@@", "citations": {"NLM": "Jung HW, Kim CY, Hong SP, Bae HJ, Choi JY, Ryu JK, Lee JB, Lee KH, Han KR, Yang DH, Park CG, Yu GW, Rhee MY, Park SJ, Hyon MS, Shin JH, Hong BK, Jin HY, Lee SY, Seol SH, Lee SR, Kim SY, Lee KJ, Cho EJ, Nam CW, Park TH, Kim U, Kim KS. Randomized, multicenter, parallel, open, phase 4 study to compare the efficacy and safety of rosuvastatin/amlodipine polypill versus atorvastatin/amlodipine polypill in hypertension patient with dyslipidemia J Clin Hypertens (Greenwich). 2023 Aug 16;():. PMID: 37584254", "BibTeX": "@article{37584254, title={Randomized, multicenter, parallel, open, phase 4 study to compare the efficacy and safety of rosuvastatin/amlodipine polypill versus atorvastatin/amlodipine polypill in hypertension patient with dyslipidemia}, author={Jung HW and Kim CY and Hong SP and Bae HJ and Choi JY and Ryu JK and Lee JB and Lee KH and Han KR and Yang DH and Park CG and Yu GW and Rhee MY and Park SJ and Hyon MS and Shin JH and Hong BK and Jin HY and Lee SY and Seol SH and Lee SR and Kim SY and Lee KJ and Cho EJ and Nam CW and Park TH and Kim U and Kim KS}, journal={J Clin Hypertens (Greenwich)}}"}}, {"_id": "32003938", "pmid": 32003938, "title": "A randomized, double-blind clinical trial to evaluate the efficacy and safety of a fixed-dose combination of amlodipine/rosuvastatin in patients with dyslipidemia and hypertension.", "journal": "J Clin Hypertens (Greenwich)", "authors": ["Kim W", "Chang K", "Cho EJ", "Ahn JC", "Yu CW", "Cho KI", "Kim YJ", "Kang DH", "Kim SY", "Lee SH", "Kim U", "Kim SJ", "Ahn YK", "Lee CH", "Shin JH", "Kim M", "Park CG"], "date": "2020-02-01T00:00:00Z", "doi": "10.1111/jch.13774", "meta_date_publication": "2020 Feb", "meta_volume": "22", "meta_issue": "2", "meta_pages": "261-269", "score": 50264.707, "text_hl": "A randomized, double-blind clinical trial to evaluate the efficacy and safety of a fixed-dose combination of @<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@amlodipine@@@/@CHEMICAL_Rosuvastatin_Calcium @CHEMICAL_MESH:D000068718 @@@rosuvastatin@@@ in @SPECIES_9606 @@@patients@@@ with @<m>DISEASE_Dyslipidemias</m> @DISEASE_MESH:D050171 @@@dyslipidemia@@@ and @DISEASE_Hypertension @DISEASE_MESH:D006973 @@@hypertension@@@.", "citations": {"NLM": "Kim W, Chang K, Cho EJ, Ahn JC, Yu CW, Cho KI, Kim YJ, Kang DH, Kim SY, Lee SH, Kim U, Kim SJ, Ahn YK, Lee CH, Shin JH, Kim M, Park CG. A randomized, double-blind clinical trial to evaluate the efficacy and safety of a fixed-dose combination of amlodipine/rosuvastatin in patients with dyslipidemia and hypertension. J Clin Hypertens (Greenwich). 2020 Feb;22(2):261-269. PMID: 32003938", "BibTeX": "@article{32003938, title={A randomized, double-blind clinical trial to evaluate the efficacy and safety of a fixed-dose combination of amlodipine/rosuvastatin in patients with dyslipidemia and hypertension.}, author={Kim W and Chang K and Cho EJ and Ahn JC and Yu CW and Cho KI and Kim YJ and Kang DH and Kim SY and Lee SH and Kim U and Kim SJ and Ahn YK and Lee CH and Shin JH and Kim M and Park CG}, journal={J Clin Hypertens (Greenwich)}, volume={22}, number={2}, pages={261-269}}"}}, {"_id": "32862551", "pmid": 32862551, "title": "Fixed-dose combination of amlodipine and atorvastatin improves clinical outcomes in patients with concomitant hypertension and dyslipidemia.", "journal": "J Clin Hypertens (Greenwich)", "authors": ["Lin CP", "Tung YC", "Hsiao FC", "Yang CH", "Kao YW", "Lin YS", "Chu YC", "Chu PH"], "date": "2020-10-01T00:00:00Z", "doi": "10.1111/jch.14016", "meta_date_publication": "2020 Oct", "meta_volume": "22", "meta_issue": "10", "meta_pages": "1846-1853", "score": 50264.184, "text_hl": "Fixed-dose combination of @<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@amlodipine@@@ and @CHEMICAL_Atorvastatin @CHEMICAL_MESH:D000069059 @@@atorvastatin@@@ improves clinical outcomes in @SPECIES_9606 @@@patients@@@ with concomitant @DISEASE_Hypertension @DISEASE_MESH:D006973 @@@hypertension@@@ and @<m>DISEASE_Dyslipidemias</m> @DISEASE_MESH:D050171 @@@dyslipidemia@@@.", "citations": {"NLM": "Lin CP, Tung YC, Hsiao FC, Yang CH, Kao YW, Lin YS, Chu YC, Chu PH. Fixed-dose combination of amlodipine and atorvastatin improves clinical outcomes in patients with concomitant hypertension and dyslipidemia. J Clin Hypertens (Greenwich). 2020 Oct;22(10):1846-1853. PMID: 32862551", "BibTeX": "@article{32862551, title={Fixed-dose combination of amlodipine and atorvastatin improves clinical outcomes in patients with concomitant hypertension and dyslipidemia.}, author={Lin CP and Tung YC and Hsiao FC and Yang CH and Kao YW and Lin YS and Chu YC and Chu PH}, journal={J Clin Hypertens (Greenwich)}, volume={22}, number={10}, pages={1846-1853}}"}}, {"_id": "39557773", "pmid": 39557773, "title": "Triple Therapy with Telmisartan, Amlodipine, and Rosuvastatin (TAR) Versus Telmisartan/Amlodipine (TA) and Telmisartan/Rosuvastatin (TR) Combinations in Hypertension and Dyslipidemia: A Systematic Review and Meta-analysis.", "journal": "High Blood Press Cardiovasc Prev", "authors": ["Habboush S", "Kagita NV", "Gadelmawla AF", "Elmoursi A", "Merza N", "Abdo AA", "Zahran AHM", "Eldeib M", "Almarghany AA", "Abdelfadil MM", "Abdelkarim MA", "Shawky I", "Mohammed OM", "Alharran A", "Ali MM", "Elbardisy S"], "date": "2024-11-19T00:00:00Z", "doi": "10.1007/s40292-024-00689-3", "meta_date_publication": "2024 Nov 19", "meta_volume": "", "meta_issue": "", "meta_pages": "", "score": 50260.48, "text_hl": "Triple Therapy with @CHEMICAL_Telmisartan @CHEMICAL_MESH:D000077333 @@@Telmisartan@@@, @<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@Amlodipine@@@, and @CHEMICAL_Rosuvastatin_Calcium @CHEMICAL_MESH:D000068718 @@@Rosuvastatin@@@ (TAR) Versus @CHEMICAL_Telmisartan @CHEMICAL_MESH:D000077333 @@@Telmisartan@@@/@<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@Amlodipine@@@ (@CHEMICAL_telmisartan_amlodipine_combination @CHEMICAL_MESH:C548840 @@@TA@@@) and @CHEMICAL_Telmisartan @CHEMICAL_MESH:D000077333 @@@Telmisartan@@@/@CHEMICAL_Rosuvastatin_Calcium @CHEMICAL_MESH:D000068718 @@@Rosuvastatin@@@ (TR) Combinations in @DISEASE_Hypertension @DISEASE_MESH:D006973 @@@Hypertension@@@ and @<m>DISEASE_Dyslipidemias</m> @DISEASE_MESH:D050171 @@@Dyslipidemia@@@: A Systematic Review and Meta-analysis.", "citations": {"NLM": "Habboush S, Kagita NV, Gadelmawla AF, Elmoursi A, Merza N, Abdo AA, Zahran AHM, Eldeib M, Almarghany AA, Abdelfadil MM, Abdelkarim MA, Shawky I, Mohammed OM, Alharran A, Ali MM, Elbardisy S. Triple Therapy with Telmisartan, Amlodipine, and Rosuvastatin (TAR) Versus Telmisartan/Amlodipine (TA) and Telmisartan/Rosuvastatin (TR) Combinations in Hypertension and Dyslipidemia: A Systematic Review and Meta-analysis. High Blood Press Cardiovasc Prev. 2024 Nov 19;():. PMID: 39557773", "BibTeX": "@article{39557773, title={Triple Therapy with Telmisartan, Amlodipine, and Rosuvastatin (TAR) Versus Telmisartan/Amlodipine (TA) and Telmisartan/Rosuvastatin (TR) Combinations in Hypertension and Dyslipidemia: A Systematic Review and Meta-analysis.}, author={Habboush S and Kagita NV and Gadelmawla AF and Elmoursi A and Merza N and Abdo AA and Zahran AHM and Eldeib M and Almarghany AA and Abdelfadil MM and Abdelkarim MA and Shawky I and Mohammed OM and Alharran A and Ali MM and Elbardisy S}, journal={High Blood Press Cardiovasc Prev}}"}}, {"_id": "37395974", "pmid": 37395974, "pmcid": "PMC10328852", "title": "A Randomized, Multicenter, Double-blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of a Quadruple Combination of Amlodipine, Losartan, Rosuvastatin, and Ezetimibe in Patients with Concomitant Essential Hypertension and Dyslipidemia", "journal": "Am J Cardiovasc Drugs", "authors": ["Kim MC", "Ahn Y", "Kim MH", "Kim SY", "Hong TJ", "Rhee MY", "Kim SH", "Hong SJ", "Kim H", "Kim W", "Chae IH", "Kang DH", "Kim BK", "Kim HS"], "date": "2023-07-01T00:00:00Z", "doi": "10.1007/s40256-023-00590-9", "meta_date_publication": "2023 Jul", "meta_volume": "23", "meta_issue": "4", "meta_pages": "441-454", "score": 50260.3, "text_hl": "A Randomized, Multicenter, Double-blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of a Quadruple Combination of @<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@Amlodipine@@@, @CHEMICAL_Losartan @CHEMICAL_MESH:D019808 @@@Losartan@@@, @CHEMICAL_Rosuvastatin_Calcium @CHEMICAL_MESH:D000068718 @@@Rosuvastatin@@@, and @CHEMICAL_Ezetimibe @CHEMICAL_MESH:D000069438 @@@Ezetimibe@@@ in @SPECIES_9606 @@@Patients@@@ with Concomitant Essential @DISEASE_Hypertension @DISEASE_MESH:D006973 @@@Hypertension@@@ and @<m>DISEASE_Dyslipidemias</m> @DISEASE_MESH:D050171 @@@Dyslipidemia@@@", "citations": {"NLM": "Kim MC, Ahn Y, Kim MH, Kim SY, Hong TJ, Rhee MY, Kim SH, Hong SJ, Kim H, Kim W, Chae IH, Kang DH, Kim BK, Kim HS. A Randomized, Multicenter, Double-blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of a Quadruple Combination of Amlodipine, Losartan, Rosuvastatin, and Ezetimibe in Patients with Concomitant Essential Hypertension and Dyslipidemia Am J Cardiovasc Drugs. 2023 Jul;23(4):441-454. PMID: 37395974", "BibTeX": "@article{37395974, title={A Randomized, Multicenter, Double-blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of a Quadruple Combination of Amlodipine, Losartan, Rosuvastatin, and Ezetimibe in Patients with Concomitant Essential Hypertension and Dyslipidemia}, author={Kim MC and Ahn Y and Kim MH and Kim SY and Hong TJ and Rhee MY and Kim SH and Hong SJ and Kim H and Kim W and Chae IH and Kang DH and Kim BK and Kim HS}, journal={Am J Cardiovasc Drugs}, volume={23}, number={4}, pages={441-454}}"}}, {"_id": "35851888", "pmid": 35851888, "title": "RP-HPLC method development and validation for simultaneous estimation of telmisartan, rosuvastatin calcium, and amlodipine besylate in combination.", "journal": "Folia Med (Plovdiv)", "authors": ["Mistry RP", "Shah C", "Jat R"], "date": "2022-02-28T00:00:00Z", "doi": "10.3897/folmed.64.e64339", "meta_date_publication": "2022 Feb 28", "meta_volume": "64", "meta_issue": "1", "meta_pages": "103-109", "score": 50256.617, "text_hl": "...INTRODUCTION: @<m>DISEASE_Dyslipidemias</m> @DISEASE_MESH:D050171 @@@Dyslipidemia@@@-@DISEASE_Hypertension @DISEASE_MESH:D006973 @@@hypertension@@@ proves to be a major risk factor for @DISEASE_Cardiovascular_Diseases @DISEASE_MESH:D002318 @@@cardiovascular diseases@@@. ", "citations": {"NLM": "Mistry RP, Shah C, Jat R. RP-HPLC method development and validation for simultaneous estimation of telmisartan, rosuvastatin calcium, and amlodipine besylate in combination. Folia Med (Plovdiv). 2022 Feb 28;64(1):103-109. PMID: 35851888", "BibTeX": "@article{35851888, title={RP-HPLC method development and validation for simultaneous estimation of telmisartan, rosuvastatin calcium, and amlodipine besylate in combination.}, author={Mistry RP and Shah C and Jat R}, journal={Folia Med (Plovdiv)}, volume={64}, number={1}, pages={103-109}}"}}]}